New York – Aug 14th, 2019 – Creative Bioarray, the world’s leading biotechnology products and services provider, announced recently the release of its flagship program – cell therapy that brings new hope for various disease. The cell therapy offered by Creative Bioarray integrates many of the immune cells for cancer immunotherapy or stem cells for regenerative medicine.
The potential clinical efficiencies of cell therapy in the field of cancer, immune disorders and cardiovascular disease are gradually attracting more researchers’ attention. Armed with a collection of cells, reagents and kits for each step of the cell therapy workflow, as well as the first-class technology platform, Creative Bioarray is capable to support immune cell therapies and stem cell therapies.
Currently, Creative Bioarray has developed methods to target specific cancer molecules using live immune cells. Our scientists are committed to extending the lifespan of immune cells and enabling them to replicate in patients, providing long-term protection against newly developed cancer cells. In addition, cells become part of the patient’s own immune system, making it a natural method for the treatment of cancer is also the goal Creative Bioarray is fighting for. Moreover, the whole workflow for the related products that will be applied for immune therapy is developed, ranging from cell collection, cell processing to cell verification and cell function. With cutting-edge technology and innovative methods, Creative Bioarray offers high quality GMP-grade clinical products to satisfy specific needs for immune cell therapy and collects types of cells, reagents, and kits can be used to treat a variety of disease.
Stem cell therapy provided by Creative Bioarray combines the latest advances in stem cell biology, embryology, tissue engineering and medicine to develop products for replacing, repairing or regenerating damaged or diseased cells and tissues. The in-house experts also developed tools used in regenerative medicine, including biological materials and extracellular matrices, laboratory-generated cells and tissues, and reagents required for treatment. As for the products required in the process of stem cell therapy, Creative Bioarray has designed and delivered healthy cells, tissues and organs for patients with chronic degenerative diseases. Furthermore, the entire workflow covering the opt of stem cell products, and cell culture, as well as cell function is supported by the professional platform and experienced scientists.
“Cancer has become a major threat to public health. However, the current treatment of cancer cannot meet the needs of patients. We believe that immune cell therapy is a new technology that has the potential to alleviate most of these chronic and degenerative diseases in a cost-effective manner,” said Hannah Cole, the marketing director of Creative Bioarray, she also claimed that, “We are excited by the clinical prospects of these revolutionary therapies, as we believe they represent a major leap forward in the future treatment of various disease.”
About Creative Bioarray
Founded in 2005, Creative Bioarray is dedicated to offering customers with innovative biotechnology products and services for research use to greatly enhance and drive innovation and standards in science. As a well-recognized industry leader with more than 10 years of experience and in-house experts supported, Creative Bioarray has already countenanced research all around the world.
Company Name: Creative Bioarray
Contact Person: Hannah Cole
Email: Send Email
Address:45-1 Ramsey Road Shirley
City: Long Island City
State: New York
Country: United States